Free Alerts   Login
Health Care › Biological Products (No Diagnostic Substances)

BCRX Stock Price Correlated With BioCryst Pharmaceuticals Financials

BCRX Stock Price vs. Quarterly
BCRX
Income Statement
Cash Flow
Balance Sheet

BCRX Income Statement

Enable JavaScript and reload
Revenue, Net:
Revenue Per Share:
Cost of Goods & Services Sold:
Gross Profit:
Selling, General & Admin Expense:
Research & Development Expense:
Total Operating Expenses:
Operating Income:
Income Taxes:
Net Income:
Earnings Per Share, Diluted:
Earnings Per Share, Basic:
Shares Outstanding, Basic Avg:
Shares Outstanding, Diluted Avg:
Common Stock Shares Outstanding:

BCRX Cash Flow

Enable JavaScript and reload
Operating Activities Net Income:
Depreciation, Depletion & Amortization:
Change in Accounts Receiveable:
Net Cash from Operations:
Net Cash from Operations Per Share:
Repurchases/Buybacks Common Stock:
Issuance of Long-term Debt:
Cash Dividends Paid:
Net Cash from Financing Activities:
Property, Plant & Equipment Purchases:
Purchases of Businesses, Net of Cash:
Net Cash from Investing Activities:
Net Change in Cash & Equivalents:

BCRX Balance Sheet

Enable JavaScript and reload
Cash and Cash Equivalents:
Short-Term Investments:
Accounts Receivable, Net:
Inventories:
Total Current Assets:
Property, Plant & Equipment, Net:
Total Assets:
Accounts Payable:
Current Portion of Long-Term Debt:
Total Short-Term Liabilities:
Long Term Debt, Non-Current Portion:
Total Long-Term Liabilities:
Total Liabilities:

Insider Trading

 
Change
Value
Transaction
SEC Form 4
Doyle Anthony   Chief Financial Officer
36,300 sh at $6
$202,191
Buy
Thackray Helen M.   Chief R&D Officer
30,000 sh at $6
$175,800
Buy
Stonehouse Jon P   President & CEO
30,000 sh at $6
$166,500
Buy
Gayer Charles K   Chief Commercial Officer
30,000 sh at $5
$164,100
Buy
Galson Steven K   Director
21,940 sh at $5
$120,451
Buy
Barnes Alane P   Chief Legal Officer
5,000 sh at $6
$27,650
Buy

Free historical financial statements for BioCryst Pharmaceuticals Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 49 quarters since 2012. Compare with BCRX stock chart to see long term trends.

Data imported from BioCryst Pharmaceuticals Inc. SEC filings. Check original filings before making any investment decision.